**5. Perspectives**

The main objective in China with respect to malaria will be focused on how to sustain malaria elimination and prevent transmission re-establishment in accordance with the WHO's newly updated guidelines [33]. This requires a specific and sustainable investment even at post-elimination stage. Malaria is on the list of the "Health China 2030" blueprint issued by the State Council of China in 2016. This will ensure the required sustainable investment. Following this blueprint, a series of technical guidelines for malaria surveillance and response at post-elimination stage, as well as protocols for preventing malaria transmission re-establishment, are under development for short release. Meanwhile, mechanisms for maintaining anti-malaria capacity in health system are implemented. A National Technical Competition for Parasitic Disease Diagnosis and Test is organized annually for health workers from clinical agencies and CDCs [54]. This competition is an efficient way to maintain awareness and efficiency in malaria detection within the health system and prevent erosion of capacity along with malaria elimination. However, malaria elimination is primarily an international endeavor. Broad engagement and sustained investments are needed with support from multiple international partners [55– 57]. In 2013, Chinese President Xi Jinping proposed the "One Belt and One Road Initiatives" to the world for international cooperation and development. Cooperation in health is one of the key components as it relates to the mutual benefits. China has already been actively involved in global health governance [58], but a higher level of involvement is now expected, and the Chinese experience in malaria elimination will definitely be put at use within the "One Belt and One Road Initiative" [59]. Several platforms are currently under development, such as the Malaria Elimination Network in Lancang-Mekong Region (MENLMR) and the China-Africa Cooperation Program. Both GMS and sub-Saharan Africa are strongly affected by malaria, including drug resistance [60–62], high disease burden [1], and low level of resources [1, 3, 34]. They are thus primary targets for focused interventions enabling malaria elimination. Furthermore, these countries are experiencing innumerable challenges to achieve their planned malaria elimination program and in dire need of international support to bridge the funding gap [1–3, 37]. Although China has applied a successful model and did significant progress on malaria elimination, the Chinese model and experience cannot directly be implemented in these countries. Evaluation and field tests are needed as preliminary steps for operational feasibility. Pilot areas have been identified, and demonstrative projects have been therefore launched jointly by China and the targeted countries to assess the level of feasibility. These preliminary projects will provide evidence-based suggestions to develop a suitable strategy and model for each country to realize the ultimate goal of malaria elimination.
